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Severe acute pancreatitis has high mortality, but multiple and timely interventions can improve survival. Early in the
course of the disease aggressive fluid resuscitation is needed for the prevention and treatment of shock. In conjunction
with leaking capillaries this results in increased tissue edema, which may lead to intra-abdominal hypertension and
abdominal compartment syndrome. Invasive hemodynamic monitoring is essential for optimizing fluid therapy while
monitoring of intra-abdominal pressure is necessary for identification patients at risk of developing abdominal
compartment syndrome. Abdominal compartment syndrome develops usually within the first days after hospitalization.
Conservative treatment modalities are useful in prevention but also in the treatment of abdominal compartment
syndrome. If conservative management fails surgical decompression of abdomen may be needed. Multiple organ
dysfunction syndrome and increased intra-abdominal pressure predispose patients with severe pancreatitis to secondary
infections. Extrapancreatic infections predominate during the first week of the disease, whereas infection of pancreatic
necrosis usually develops later. Early enteral nutrition reduces the risk of infections whereas advantage of prophylactic
antibiotics is lacking evidence. Surgery for infected pancreatic necrosis is associated with high mortality when performed
within the first two weeks of the disease. Therefore surgery should be postponed as late as possible, preferably later than
four weeks after disease onset.Introduction
In the majority of patients acute pancreatitis is a mild
self-limiting disease. About fifteen percent of the patients
develop severe disease defined by development of persist-
ent organ failure [1]. The mortality in acute pancreatitis is
mainly associated with multiple organ failure [2] whereas
the risk of dying is minimal in patients with no or transi-
ent organ dysfunction [3,4]. In acute pancreatitis, multiple
organ failure is a consequence of excessive activation of a
systemic inflammatory response cascade [5]. Inflammatory
mediators induce end-organ endothelial cell activation
leading to increased permeability [6]. Leaking microvessels
cause a loss of intravascular fluid and in conjunction with
vasodilatation lead to hypotension and shock. Accumula-
tion of inflammatory cells in tissues, increased interstitial
fluid and activation of coagulation with microvascular
thrombosis further impair oxygen supply of tissues. Clinical
manifestation of all this is a multiple organ dysfunction
syndrome (MODS), which develops early during the course* Correspondence: ari.leppaniemi@hus.fi
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article, unless otherwise stated.of acute pancreatitis. Over half of the patients with severe
pancreatitis have signs of organ dysfunction on hospital
admission [3] and most of the organ dysfunctions develop
within the first four days after admission [7]. Over half of
the deaths occur within the first week from onset of the
disease, and deaths usually occurred within a week after
manifestation of MODS [8].
Treatment modalities of MODS are supportive includ-
ing fluid replacement therapy, vasopressors, mechanical
ventilation and renal replacement therapy when necessary.
In patients with acute pancreatitis, abdominal compartment
syndrome (ACS) may aggravate MODS, and therefore,
monitoring of intra-abdominal pressure (IAP) is crucial for
identification of patients at risk of ACS [9]. Development
of ACS should be prevented, if possible, by conservative
methods. Surgical decompression is the last but the most
effective way to decrease IAP and should not be postponed
too late if patient has developed ACS [10].
Patients with acute pancreatitis have a considerable risk
for developing secondary infections including bacteremia,
pneumonia and infection of pancreatic or peripancreatic
necrosis. Extrapancreatic infections occur predominantly
during the first week of illness, whereas pancreatic necrosisMed Central Ltd. This is an Open Access article distributed under the terms of
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in patients with persistent organ failure complicated
with infected pancreatic necrosis [12]. Development of
bacteremia and infected pancreatic necrosis are associated
with MODS. Intestinal dysfunction plays an important
role and bacterial translocation from intestine is con-
sidered the main mechanism of infection. Impaired
host response systems may also predispose to clinical
infections. Early enteral nutrition has been shown to
reduce systemic infections [13], whereas the results from
randomized trials with prophylactic antibiotics have been
inconclusive [14]. Surgery is considered necessary for
adequate source control when pancreatic or peripan-
creatic infection develops. However, because surgery
for pancreatic necrosis within the first 2–3 weeks from
disease onset is associated with high mortality, surgery
should be postponed as late as possible [15]. Sometimes
percutaneous drainage of fluid from infected acute
necrotic collection may be helpful and is preferable
first-line treatment for infected pancreatic necrosis during
the first three weeks of illness [16].
Fluid resuscitation and abdominal compartment syndrome
Aggressive fluid therapy during the early phase of acute
pancreatitis has been traditionally the cornerstone of treat-
ment [17]. The rationale of fluid therapy is to correct
hypovolemia caused by third space fluid loss. High
admission hematocrit (above normal reference limits)
may serve as a marker of hemoconcentration, and it is
present up to 60% of patients who develop organ failure
[18], but the marker is too unspecific for predictive
purposes [19]. Fluid resuscitation decreases hematocrit,
which could be used as resuscitation end-point. Too
aggressive resuscitation may lead to inappropriate he-
modilution and very low hematocrit values (<30%) may
be harmful for the patients by increasing the risk of sepsis
and death [20]. Moreover, excess volume loading may
increase IAP and lead to development of intra-abdominal
hypertension (IAH) and abdominal compartment syn-
drome [21]. In patients with acute pancreatitis, hematocrit
and central venous pressure as resuscitation end-points
are poor indicators of volume depletion [22]. Urine output
(≥0.5 ml/kg/h) may serve as another resuscitation end-
point, but other modalities are needed for volume man-
agement if oliguria persists after initial volume loading.
According to recent systematic review there is little
evidence concerning the rate of infusion, optimal resusci-
tation end-point and the type of fluid in patients with
acute pancreatitis [23].
In those patients with pancreatitis who develop shock
the same management guidelines as for septic shock
patients can be applied. These include initial fluid chal-
lenge with crystalloids (rate 1000 ml/ hour) with minimum
of 30 ml/kg and administration of vasopressor epinephrineto maintain adequate blood pressure [24]. Principles of
early goal directed resuscitation with monitoring of CVP,
MAP and either central venous oxygen saturation or
mixed venous oxygen saturation [25] can be used also
in acute pancreatitis. Frequently elevated IAP should be
monitored and taken into account when considering
resuscitation end-points [26]. Abdominal perfusion pres-
sure (APP) could serve as a good resuscitation end-point
in patients with IAH [27]. Maintaining APP above 50–
60 mmHg is recommended in order to provide sufficient
perfusion to abdominal organs [28]. Lactate level should
be monitored and resuscitation should be targeted to
normalizing the lactate level. As soon as resuscitation
end-points are reached, the infusion rate should be slowed
down in order to avoid fluid overloading.
Although the use of colloids can reduce overall volume
needed for resuscitation, and thus, could decrease the
risk of developing IAH, the use of colloids is not recom-
mended in the guidelines of severe sepsis and septic
shock [24]. Hydroxyethyl starch (HES) does not provide
any benefit compared with normal saline and its use is
associated with increased need for renal replacement
therapy [29].
In severe pancreatitis IAH develops as a result of fluid
resuscitation and capillary leakage. Fluid accumulates into
retroperitoneal space, ascites may form and tissues edema
develops. In addition, paralytic bowel can contain substan-
tial amounts of fluid and air. All this takes space in the
abdominal cavity, which causes distension of the abdom-
inal wall. Abdomen can tolerate increased volume to some
extent, but when abdominal wall becomes distended
increasing intra-abdominal volume cause elevation in IAP.
When IAH (IAP ≥12 mmHg) develops conservative
methods should be applied to prevent development of
ACS. These include restriction of intravenous fluids if
possible, gastrointestinal decompression with nasogastric
tube, and drainage of ascites fluid [30]. Abdominal wall
compliance can be increased with adequate pain manage-
ment; intubation and sedation usually decreases IAP and
sometimes even neuromuscular blockade can be used
for this purpose. An effective way to correct positive
fluid balance and prevent development of ACS is early
introducing of hemofiltration [31].
Renal function is impaired already at IAP level as low
as 12 mmHg [32]. In patients with established IAH, IAP
and APP should be monitored. A patient with shock can
easily have inappropriately low APP (<50 - 60 mmHg)
even with moderate IAH. Poor perfusion increases bowel
mucosal injury [33], which is associated with infectious
complications and organ failure in patients with pan-
creatitis [34]. IAH may play significant role in ischemic
bowel complications [35]. Colonic necrosis [36] but also
ischemic small bowel [37] can sometimes complicate to
course of severe pancreatitis, but the role of IAH in
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plays a major role in early mortality caused by multiple
organ failure in acute pancreatitis. Our own observation
supports this: Pancreatitis patients with ACS had severe
multi organ failure early during the course of the disease
and early surgical decompression was associated with
reduced mortality and none of the patients treated with
decompression died during the first week [10].
In most cases adequate and timely conservative man-
agement including ascites drainage [30] is successful,
but if ACS develops despite these interventions, surgical
decompression should be done without a delay. Midline
laparostomy that allows inspection of bowel viability is
recommended in order to diagnose possible ischemic
lesions. In acute pancreatitis surgical decompression
usually leads to open abdomen of several weeks duration
[10]. Vacuum assisted closure with mesh mediated
fascial traction is a superior temporary abdominal closure
method with low frequency of giant hernias [38,39].
Nutrition
There are no indications for fasting in pancreatitis.
Although pancreatitis patient may have nausea and
vomiting early during the course, these symptoms usually
resolve rapidly. In patients with mild acute pancreatitis
oral feeding can be started as soon as patient tolerates
food; early oral feeding has been associated with faster
recovery and shorter hospital stay [40]. In pancreatitis
enteral feeding is superior to parenteral feeding. Enteral
nutrition prevents bacterial overgrowth in the intestine
and reduces bacterial translocation [41]. In pancreatitis
enteral nutrition reduces significantly systemic infections,
organ dysfunction and mortality [13,42]. Critically ill
patients are typically at risk of malnutrition [43] and
therefore nutrition of patients with acute pancreatitis
should be initiated as soon as possible. Initiation of enteral
feeding seems to be critical in pancreatitis; if delayed for
more than 48 hours, the benefits from enteral feeding are
lost [44,45]. The route of enteral feeding can be either
gastric or post pyloric. Gastric feeding succeeds in most
of the patients, and therefore feeding can be initiated
by using a nasogastric tube [46]. Delayed gastric emptying
may cause problems, and therefore gastric residual volume
should be monitored every six hours. It is recommended
that tube feeding is started with low infusion rate (10 ml/h)
and increased by 10 ml/h until every six hours providing
that gastric residual volume is below 250 ml [43]. This
should be continued until target volume of enteral nutri-
tion is achieved. If gastric emptying is problem prokinetics
may help but better option is to place nasojejunal feeding
tube, which usually resolves the problem. If patient
does not tolerate required volume of enteral nutrition,
parenteral nutrition can be combined with enteral so
that caloric needs are fulfilled.Infections and the use of antibiotics
A quarter of patients with acute pancreatitis develop
infectious complication [11]. Patients with severe acute
pancreatitis are more susceptible to develop infections
[11]. Patients with organ dysfunctions have higher inci-
dence of bacterial translocation [34]. They also have
impaired immune system [7]. The majority of infections
are extrapancreatic such as bacteremia and pneumonia.
The half of these infections develop within the first week
post admission [11]. Diagnosis of infected pancreatic
necrosis is usually done significantly later, the peak inci-
dence is between the third and fourth week from the onset
of symptoms [11,47]. However, the actual contamination
of necrosis happens probably much earlier [48]. Organ
failure, early bacteremia and the extent of pancreatic
necrosis are associated with increased risk of infected
necrosis [11]. Diagnosis of infected pancreatic necrosis
is challenging. Clinical signs of sepsis are too unspecific
for definitive diagnosis and CT-scan shows gas bubbles in
the necrotic collection in less than ten percent of patients
[49]. Fine needle aspiration with bacterial culture has a
substantial rate (20-25%) of false negative results, and
thus, is not reliable to rule out infection [50].
Prophylactic antibiotics have been studied in many
randomized trials with conflicting results and according
to several meta-analyses and systematic reviews there is
no evidence that patients benefit from prophylactic antibi-
otics [14,51,52]. However, there has been a nonsignificant
trend for lower mortality and reduced number of infec-
tions, especially extrapancreatic infections in patients
treated with prophylactic antibiotics. The randomized
trials have been conducted with small samples sizes and
some studies included a substantial number of patients
with mild pancreatitis [53] with minimal risk of mortality
and low risk of infectious complications. Although trials
have not provided evidence that prophylactic antibiotic
are effective they have not proved that they are not effect-
ive [54]. Taken together the limitations of the trials and
the fact that patients with organ failure are susceptible
to infections, we believe that the use of prophylactic
antibiotic in patients with severe pancreatitis is justified.
High incidence of infections in patients with severe
pancreatitis and worse survival in patients who develop
infection supports this policy. Indication for initiation
of prophylactic antibiotics should be based on clinical
judgment. Systemic inflammatory response syndrome
(SIRS) [4], signs of organ dysfunction, presence of IAH
[55], hyperglycemia, low plasma calcium or high creatin-
ine [56] could be helpful in predicting severe disease.
If prophylactic antibiotics are not given, empiric use of
antibiotics is encouraged in patients who develop organ
dysfunctions, because there is high risk of bacteremia
during the first week. Patients with severe pancreatitis
fulfill the criteria of severe sepsis in case of infection and
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to rule out infection. Delayed administration of antibiotics
has been shown to worsen survival in patients with severe
sepsis with or without septic shock [57]. After the end
of the second week, empiric antibiotics may be needed
for treatment of infected pancreatic necrosis if sepsis
continues or the patient does not recover. Empiric anti-
biotics at this stage should cover potential pathogens
including gram negative rods and gram positive cocci
[47]. The role of empiric antifungals is not clear. Fine
needle aspiration for microbiological samples should be
taken if infected necrosis is suspected, although negative
samples do not rule out infection [50]. Positive samples
help in selection of antimicrobials and initiation of pos-
sible antifungal therapy. Prophylactic or empiric antibiotic
should be discontinued when the patient recovers from
organ dysfunctions and there is no evidence of infection.
Surgery for infected necrosis
Infected pancreatic or peripancreatic necrosis has trad-
itionally been considered an indisputable indication for
surgical debridement [58]. Infected necrosis is a significant
source of sepsis and removal of devitalized tissue is believed
to be necessary for control of sepsis. However, infection
usually continues after necrosectomy, especially if necrotic
tissue is left in place. Before demarcation of necrosis
develops, usually after 4 weeks from disease onset, it is
impossible to remove all necrotic tissue without causing
hemorrhage. Early surgical debridement has been associ-
ated with high risk of hemorrhage leading to increased
organ dysfunction and death. If necrosectomy for infected
pancreatic necrosis is done within the first two weeks the
mortality rate is 75%, but gradually decreases to 5% when
done later than four weeks after the onset of symptoms
[15,50,59]. Multiple organ dysfunction increases mortality
risk considerably in patients with infected necrosis. The
mortality rate increases in proportion to the number of
failed organs [50]. Infected pancreatic necrosis does not
cause significant risk of death in absence of organ dys-
function [12,50]. Because high mortality is associated
with early surgery and multiple organ dysfunction, it is
recommended that surgery for infected necrosis should
be postponed as late as possible, preferable later than
four week from disease onset. Percutaneus drainage of
the liquid component of the infected acute necrotic
collection may serve as a bridge to surgery [16]. Sterile
collections do not need drainage. Placement of a drain
into a sterile necrotic collection can result in secondary
infection, and a prolonged drainage may increase the
risk further [60,61].
Infected pancreatic necrosis may cause worsening of
multiple organ failure between the second and fourth
week of the disease. Although delayed operative treatment
is associated with lower mortality rate [62], it is not alwayspossible to postpone surgery, if the condition of the pa-
tient deteriorates. Indeed, patients operated on between
days 14 and 29 from admission have significantly higher
prevalence of organ failure than patients operated on later
than day 29 from admission [62], which may partly explain
differences in mortality. There are no randomized studies
comparing operative treatment and catheter drainage
in this subgroup of patients with worsening multiple
organ failure after two weeks from disease onset. The
only randomized trial comparing open necrosectomy
and minimally invasive step-up approach included only
28 (32%) patients with multiple organ failure and the
median time of interventions was 30 days from disease
onset [63]. In this study, the mortality rate was the same
between the groups. Unfortunately, no data of subgroup
analysis of patients with multiple organ failure was
shown [63]. Although the use mini-invasive techniques
are increasingly used for infected pancreatic necrosis,
the lowest published mortality rate in patients operated on
for infected necrosis is with open debridement and closed
packing with 15% mortality [50]. In patients without pre-
operative organ failure, minimally invasive necrosectomy
is associated with fewer new-onset organ failure than open
surgery [63]. However, a considerable number of patients
are not suitable for mini-invasive surgery either because
of localization of the necrotic collection or because intra-
abdominal catastrophe needs to be excluded [64].
Recommendations
The management of patients with acute pancreatitis de-
pends on duration of the disease. The following guidelines
are provided for specific time frames.
A. On admission
1. Diagnosis of acute pancreatitis is completed. Use CT-
scan without contrast in case of diagnostic uncertainty.
2. Initiate fluid resuscitation with crystalloids for
correction of hypovolemia with simultaneous
monitoring of vital organ functions including
IAP monitoring.
3. Assess severity based on clinical judgment and
initiate prophylactic antibiotics in patients with
probable severe pancreatitis.
4. If patient has any signs of organ dysfunction
consider intensive care admission.
B. Within the first 48 hours from admission
1. Re-assess the severity daily and discontinue
prophylactic antibiotics in patients with mild or
moderate pancreatitis.
2. Continue monitoring of vital organ functions and
IAP in accordance with fluid therapy. Optimize fluid
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patient is hemodynamically stable and does not
show signs of dehydration.
3. If the patient has signs of deteriorating organ functions
consider intensive care admission in order to start
invasive hemodynamic monitoring and critical care.
4. In patients with IAH, calculate APP and use
conservative efforts to prevent development of ACS.
5. In case ACS develops or the patient has low APP,
use all possible conservative efforts to reduce IAP
and correct APP, but if not effective perform surgical
decompression with midline laparostomy.
6. Take blood cultures and plain chest radiographs for
detection of infections.
7. Initiate enteral nutrition.
C. Within the first week from disease onset
1. Same as B1 – B6.
2. Continue enteral nutrition, target for total caloric
needs through enteral route.
3. Perform contrast enhanced CT-scan on days 5–7
after disease onset in patients with normal renal
function. The amount and localization of necrosis
may help in predicting the need of follow-up for
late complications.
D. During the second week from disease onset
1. Continue supportive care; try to get rid of excessive
third space fluids if possible.
2. If the patient is septic at end of the second week or
later, consider repeat CT-scan with image guided
FNA and after that consider empiric antibiotics for
possible infected pancreatic necrosis.
3. If infected necrosis is diagnosed, image guided
percutaneous drainage of collection should be done.
4. An alternative to FNA is to put a percutaneous
drain directly into the collection and take samples,
however, if cultures are negative the drain should be
removed as prolonged drainage may cause increased
risk for infection.
5. Surgery for infected pancreatic necrosis should be
avoided during the first two weeks, because necrosis
is not well demarcated and surgery it is associated
with high risk of hemorrhage and high mortality.
E. After the second week from disease onset
1. Same as D1 – D4, repeat CT-scan if patient
deteriorates; repeat CT-scan weekly if the patient is
not recovering.
2. Percutaneus drainage of infected pancreatic
necrosis can be continued if the patient shows signsof recovery, some patients may even avoid
surgical treatment.
3. If the patient is deteriorating despite of setting
of percutaneous drainage, proceed to surgical
necrosectomy, whether there is proven infection
or not.
4. In patients who do not recover but are stable,
surgery for pancreatic necrosis is possible, but
should be postponed as late as possible, preferably
later than 4 weeks after disease onset. CT-scan
before surgery is recommended for localization of
necrosis and to confirm the demarcation of necrosis.
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